Merrimack, CTCA Collaborate to Accelerate Individualized Treatment of Cancer | GenomeWeb

NEW YORK (GenomeWeb News) – Merrimack Pharmaceuticals and the Cancer Treatment Centers of America announced a research collaboration to better understand cancer on the molecular level and accelerate personalized treatments for the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.